*Pre-Registration Required
Live In-Person Event
Interactive continuing medical education activity for healthcare professionals in Philadelphia, New Jersey, Delaware, and surrounding areas to discuss myeloma updates and challenges in treatment.
Hilton Philadelphia City Avenue
4200 City Avenue
Philadelphia, PA 19131
Target Audience
Practicing hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma and AL amyloidosis.
Agenda
6:15 PM – Dinner and networking
7:00 PM – Welcome and program overview
Edward Stadtmauer, MD and Adam Binder, MD
7:05 PM –Blood Cancer United resources
Lauren Berger, MPH
7:10 PM – Case presentation and discussion: What to do after first relapse following initial treatment? Focus on immunotherapies
Rachel Thomas, MD and Asya Varshavsky-Yanovsky, MD, PhD
7:45 PM – Case presentation and discussion: Turning out the lights in AL Amyloidosis
Adam Binder, MD and Sean Reilly, MD
8:15 PM – Case presentation and discussion: Newest targeted therapies for R/R: Focus on Small-Molecule Inhibitors based on NGS and other targets
Kaitlin Demarest, MD and Edward Stadtmauer, MD
8:45 PM – Discussion & Wrap-Up
9:00 PM – Conclusion
Learning Objectives
At the conclusion of this activity, participants will be better able to:
- Describe the latest developments in myeloma, including combination therapies, bispecific antibodies, and CAR T-cell therapies
- Engage patients and caregivers in discussions on clinical trials to treat myeloma
- Explain disparities and challenges in diagnosis and treatment of myeloma
- Apply evidence-based treatment strategies for optimal patient care
- Identify resources for patient education and support
ADVISORY GROUP
Edward A. Stadtmauer, MD (Chair)
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Adam Binder, MD (Chair)
Thomas Jefferson University Hospital
Philadelphia, PA
Tulin Budak-Alpdogan, MD
Cooper University Health Care
Camden, NJ
Asya Varshavsky-Yanovsky, MD, PhD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Adam Waxman, MD, MS
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Heather Woods, MSN, CRNP, FNP-C
Temple-Fox Chase Cancer Center
Philadelphia, PA
FACULTY
Edward A. Stadtmauer, MD (Chair)
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Adam Binder, MD (Chair)
Thomas Jefferson University Hospital
Philadelphia, PA
Kaitlin Demarest, MD
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Lauren Berger, MPH
Blood Cancer United
Washington, DC
Sean P. Reilly, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Rachel J. Thomas, MD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Asya Varshavsky-Yanovsky, MD, PhD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Blood Cancer United and Medical Learning Institute Inc. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of Blood Cancer United under Provider Number CEP 5832 to award 2.0 continuing education contact hours through the California Board of Registered Nursing.
Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-26-013-L01-P
For Pharmacists, Medical Learning Institute Inc will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form, and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at [email protected].
Providers
This activity is provided by Blood Cancer United and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporter
There is no commercial support associated with this activity.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at [email protected].